Home › NDC Lookup › RxCUI directory › RxCUI 2385348

Citric acid 0.01 MG/MG / lactic acid 0.018 MG/MG / potassium bitartrate 0.004 MG/MG Vagina... — RxCUI 2385348

RxNorm drug concept · Semantic clinical drug
RxCUI 2385348 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2385348
Official nameCitric acid 0.01 MG/MG / lactic acid 0.018 MG/MG / potassium bitartrate 0.004 MG/MG Vaginal Gel
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslactic acid 1.8 % / citric acid 1 % / potassium bitartrate 0.4 % Vaginal Gel; citric acid 0.01 MG/MG / lactic acid 0.018 MG/MG / K+ bitartrate 0.004 MG/MG Vaginal Gel; citric acid 0.01 MG/MG / lactic acid 0.018 MG/MG / Pot bitartrate 0.004 MG/MG Vaginal Gel
FDA products mapped2
Package NDCs mapped3
Reported Medicaid activity (SDUD)17,596 prescriptions · 36 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lactic Acid, Citric Acid, and Potassium Bitartrate Vaginal Contraceptive: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Only when you have sex — that's the whole point of it being an on-demand contraceptive. You insert one applicator vaginally up to an hour before intercourse, and that's it. No dail...
  • Do I have to use PHEXXI every day, or only when I have sex?
  • Yes, absolutely. PHEXXI is compatible with latex, polyurethane, and polyisoprene condoms, diaphragms, and hormonal contraceptives like the pill. The one thing to avoid is using it...
  • Can I use PHEXXI with condoms or my birth control pill?
📖 Read our full Lactic Acid, Citric Acid, and Potassium Bitartrate Vaginal Contraceptive guide →

🕸️ Concept Web — How Citric acid 0.01 MG/MG / lactic acid 0.018 MG/MG... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Citric acid 0.01 MG/MG / lactic acid 0.018 MG/MG / potassium bitartrate 0.004 MG/MG Vaginal Gel RxCUI 2385348

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Citric acid 21183
    • Lactate 114202
    • Potassium bitartrate 223779
    • Citric acid / lactate / potassium bitartrate 2385347
    • Lactic acid 28393
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Phexx 2700381
    • Phexxi 2385349
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Citric acid / lactate / potassium bitartrate Vaginal Gel 2385346
    • Citric acid / lactic acid / potassium bitartrate Vaginal Gel 2646886
    • Citric acid / lactate / potassium bitartrate Vaginal Product 2385345
    • Citric acid / lactic acid / potassium bitartrate Vaginal Product 2661447
    • Citric acid / lactate / potassium bitartrate Vaginal Gel [Phexx] 2700384
    • Citric acid / lactate / potassium bitartrate Vaginal Gel [Phexxi] 2385351
    • Citric acid / lactic acid / potassium bitartrate Vaginal Gel [Phexx] 2700385
    • Citric acid / lactic acid / potassium bitartrate Vaginal Gel [Phexxi] 2657403
    • +4 more in this family
  4. Clinical & branded drugs 7

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 22 of 26 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Citric acid 0.01 MG/MG SCDC · 2385342
  • Lactic acid 0.018 MG/MG SCDC · 2385343
  • Potassium bitartrate 0.004 MG/MG SCDC · 2385344
  • Citric acid / lactate / potassium bitartrate Vaginal Gel SCDF · 2385346
  • Citric acid / lactic acid / potassium bitartrate Vaginal Gel SCDFP · 2646886
  • Citric acid / lactate / potassium bitartrate Vaginal Product SCDG · 2385345
  • Citric acid / lactic acid / potassium bitartrate Vaginal Product SCDGP · 2661447

Brand-Name Concepts

📦 FDA Products & Package NDCs

2 products · 3 package NDCs
3 package NDCs map to RxCUI 2385348 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
69751-0100-03 3 APPLICATOR in 1 BOX (69751-100-03) / 5 g in 1 APPLICATOR... Phexxi Evofem, Inc. 2021-05-24
69751-0100-12 12 APPLICATOR in 1 BOX (69751-100-12) / 5 g in 1 APPLICATOR... Phexxi Evofem, Inc. 2020-09-01
69751-0101-12 12 APPLICATOR in 1 BOX (69751-101-12) / 5 g in 1 APPLICATOR... Phexx Evofem, Inc. 2020-09-01
Observed labelers: Evofem, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$6.0515
Range $6.0515–$6.0515 · middle 50% $6.0515–$6.0515 · 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.